𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A guide to economic evaluation: Methods for cost-effectiveness analysis of person-level data

✍ Scribed by Jeffrey S. Hoch; Mark W. Smith


Publisher
Springer
Year
2006
Tongue
English
Weight
151 KB
Volume
19
Category
Article
ISSN
0894-9867

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The authors introduce economic evaluation with particular attention to cost‐effectiveness analysis. They begin by establishing why health care decisions should be guided by economics. They then explore different types of economic evaluations. To illustrate how to conduct and evaluate a cost‐effectiveness analysis, a hypothetical study about the treatment of posttraumatic stress disorder with psychotherapy versus pharmacotherapy is considered. The authors conclude with recommendations for increasing the strength and relevance of economic evaluations.


πŸ“œ SIMILAR VOLUMES


The economics of information: A guide to
✍ Snyder, Herbert πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 22 KB πŸ‘ 2 views

guistic analysis, associating spatial prepositions with a cognitive retrieval, information science research has recently been investigating systems that rely on the interaction of the conceptual map in the brain. Other phenomena illustrate the complexity of the interaction and spatial systems of th

Societal value, the person trade-off, an
✍ Peter A. Ubel; Jeff Richardson; Paul Menzel πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 2 views

In a previous paper, it was argued that Societal Value measurement through person trade-off (PTO) elicitation offers a way to include the values of both general public and patients into cost-effectiveness analysis (CEA). It was said that patients' values could be used to estimate the effect that var

Estimating survival gain for economic ev
✍ N. Neymark; I. Adriaenssen; T. Gorlia; S. Caleo; M. Bolla πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 240 KB πŸ‘ 1 views

## Abstract The problem of estimating expected outcomes for the economic evaluation of treatments for which the outcome of principal interest is (quality adjusted) survival time has so far not received sufficient attention in the literature. The best estimate of expected survival is mean survival t